Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation.

Zhao YH, Wang ZF, Pan ZY, Péus D, Delgado-Fernandez J, Pallud J, Li ZQ.

Front Neurol. 2019 Mar 26;10:286. doi: 10.3389/fneur.2019.00286. eCollection 2019.

2.

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.

Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218.

PMID:
25242542
3.

The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis.

Zhao YH, Wang ZF, Cao CJ, Weng H, Xu CS, Li K, Li JL, Lan J, Zeng XT, Li ZQ.

Front Neurol. 2018 Mar 21;9:127. doi: 10.3389/fneur.2018.00127. eCollection 2018.

4.

Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.

Azoulay M, Santos F, Shenouda G, Petrecca K, Oweida A, Guiot MC, Owen S, Panet-Raymond V, Souhami L, Abdulkarim BS.

J Neurooncol. 2017 May;132(3):419-426. doi: 10.1007/s11060-017-2383-2. Epub 2017 Apr 3.

PMID:
28374095
5.

The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review.

Wang Y, Xing D, Zhao M, Wang J, Yang Y.

PLoS One. 2016 Mar 23;11(3):e0152170. doi: 10.1371/journal.pone.0152170. eCollection 2016. Review.

6.

Survival Benefit of Maximal Resection for Glioblastoma Reoperation in the Temozolomide Era: A Meta-Analysis.

Lu VM, Goyal A, Graffeo CS, Perry A, Burns TC, Parney IF, Quinones-Hinojosa A, Chaichana KL.

World Neurosurg. 2019 Jul;127:31-37. doi: 10.1016/j.wneu.2019.03.250. Epub 2019 Apr 1. Review.

PMID:
30947000
7.

Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.

Yong RL, Wu T, Mihatov N, Shen MJ, Brown MA, Zaghloul KA, Park GE, Park JK.

J Neurosurg. 2014 Oct;121(4):802-9. doi: 10.3171/2014.6.JNS132038. Epub 2014 Jul 25.

PMID:
25061868
8.

Reoperation for Recurrent Glioblastoma Multiforme.

Robin AM, Lee I, Kalkanis SN.

Neurosurg Clin N Am. 2017 Jul;28(3):407-428. doi: 10.1016/j.nec.2017.02.007. Review.

PMID:
28600015
9.

National Trends for Reoperation in Older Patients with Glioblastoma.

Chen YR, Sole J, Ugiliweneza B, Johnson E, Burton E, Woo SY, Koutourousiou M, Williams B, Boakye M, Skirboll S.

World Neurosurg. 2018 May;113:e179-e189. doi: 10.1016/j.wneu.2018.01.211. Epub 2018 Feb 7.

PMID:
29427817
10.

γ knife surgery versus reoperation for recurrent glioblastoma multiforme.

Skeie BS, Enger PØ, Brøgger J, Ganz JC, Thorsen F, Heggdal JI, Pedersen PH.

World Neurosurg. 2012 Dec;78(6):658-69. doi: 10.1016/j.wneu.2012.03.024. Epub 2012 Apr 4.

PMID:
22484078
11.

Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.

Shwetha SD, Shastry AH, Arivazhagan A, Santosh V.

Pathol Res Pract. 2016 Jan;212(1):17-23. doi: 10.1016/j.prp.2015.11.002. Epub 2015 Nov 14.

PMID:
26616112
12.

Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.

Delgado-Fernandez J, Garcia-Pallero MÁ, Blasco G, Penanes JR, Gil-Simoes R, Pulido P, Sola RG.

World Neurosurg. 2017 Dec;108:610-617. doi: 10.1016/j.wneu.2017.09.062. Epub 2017 Sep 20.

PMID:
28939537
13.

Scale to predict survival after surgery for recurrent glioblastoma multiforme.

Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM.

J Clin Oncol. 2010 Aug 20;28(24):3838-43. doi: 10.1200/JCO.2010.30.0582. Epub 2010 Jul 19.

14.

Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.

Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1133-9.

PMID:
15990019
15.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
16.

The efficacy of temozolomide for recurrent glioblastoma multiforme.

Chen C, Xu T, Lu Y, Chen J, Wu S.

Eur J Neurol. 2013 Feb;20(2):223-30. doi: 10.1111/j.1468-1331.2012.03778.x. Epub 2012 Jun 11. Review.

PMID:
22680781
17.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
18.

Outcome of salvage treatment for recurrent glioblastoma.

Kim HR, Kim KH, Kong DS, Seol HJ, Nam DH, Lim DH, Lee JI.

J Clin Neurosci. 2015 Mar;22(3):468-73. doi: 10.1016/j.jocn.2014.09.018. Epub 2015 Jan 13.

PMID:
25595963
19.

A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.

Konar SK, Bir SC, Maiti TK, Nanda A.

J Neurosurg Pediatr. 2017 Feb;19(2):239-248. doi: 10.3171/2016.8.PEDS1631. Epub 2016 Nov 4. Review.

PMID:
27813458
20.

Supplemental Content

Support Center